Amended And Restated Employment AgreementEmployment Agreement • March 16th, 2009 • Cardiac Science CORP • Surgical & medical instruments & apparatus
Contract Type FiledMarch 16th, 2009 Company IndustryThis Amended and Restated Employment Agreement (this “Agreement”), dated as of Sept. 20, 2006, is between Cardiac Science Corporation, a Delaware corporation (the “the Company”), and Feroze Motafram, Vice President, Operations (“Executive”);
CARDIAC SCIENCE CORPORATION 2002 STOCK INCENTIVE PLAN FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • March 16th, 2009 • Cardiac Science CORP • Surgical & medical instruments & apparatus • Washington
Contract Type FiledMarch 16th, 2009 Company Industry JurisdictionPursuant to your Restricted Stock Unit Award Notice (the “Award Notice”) and this Restricted Stock Unit Award Agreement (this “Agreement”), Cardiac Science Corporation (the “Company”) has granted you a Restricted Stock Unit Award (the “Award”) under its 2002 Stock Incentive Plan (the “Plan”) with respect to the number of Restricted Stock Units indicated in your Award Notice. Capitalized terms not explicitly defined in this Agreement but defined in the Plan shall have the same definitions as in the Plan.
LeaseLease Agreement • March 16th, 2009 • Cardiac Science CORP • Surgical & medical instruments & apparatus
Contract Type FiledMarch 16th, 2009 Company IndustryThis Lease Agreement made as of the 26th day of November, 2008 by and between Carl Ruedebusch LLC (herein “Landlord”) and Cardiac Science Corporation (“Tenant”). For good and valuable consideration, the receipt and adequacy of which is acknowledged, Landlord and Tenant hereby agree as follows:
OEM SUPPLY AND PURCHASE AGREEMENTOem Supply and Purchase Agreement • March 16th, 2009 • Cardiac Science CORP • Surgical & medical instruments & apparatus • Tokyo
Contract Type FiledMarch 16th, 2009 Company Industry JurisdictionThis OEM Supply and Purchase Agreement (“Agreement”) is made as of March 31, 2005 by and between Nihon Kohden Corporation, a Japanese Corporation with its principal offices at 31-4 Nishiochiai 1-chome, Shinjuku-ku, Tokyo 161-8560 Japan (hereinafter referred to as “NK”), and Cardiac Science Inc., a Delaware Corporation with its principal offices at 1900 Main Street, Irvine, California, USA 92614 (hereinafter referred to as “CSI”) (NK and CSI each being a “Party”, and collectively the “Parties”).